Innoviva (INVA) Other Non-Current Liabilities (2014 - 2026)

Innoviva (INVA) posted Other Non-Current Liabilities of $69.1 million for Q1 2026, up 21.21% on a QoQ basis from $57.0 million in Q4 2025, and up 485.92% year-over-year from $11.8 million in Q1 2025.

Innoviva (INVA) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends

Innoviva's Other Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $69.1 million for Q1 2026.

  • Quarterly Other Non-Current Liabilities rose 485.92% year-over-year to $69.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69.1 million (up 485.92% YoY) and the FY2025 annual result came in at $57.0 million, down 11.3% from the prior year.
  • Other Non-Current Liabilities was $69.1 million for Q1 2026 at Innoviva, up from $57.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $78.4 million in Q3 2022 and bottomed at $1.1 million in Q3 2024.
  • A 5-year average of $58.8 million and a median of $68.6 million in 2023 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Other Non-Current Liabilities soared 560050.0% — and 2024, when it sank 98.43%.
  • Innoviva's Other Non-Current Liabilities stood at $67.9 million in 2022, then grew by 5.77% to $71.9 million in 2023, then declined by 10.57% to $64.3 million in 2024, then slipped by 11.3% to $57.0 million in 2025, then advanced by 21.21% to $69.1 million in 2026.
  • Business Quant data shows INVA's Other Non-Current Liabilities at $69.1 million in Q1 2026, $57.0 million in Q4 2025, and $55.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Innoviva 1.57 Bn 969.11 Mn 75.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 69.10 Mn
Dec 31, 2025 57.01 Mn
Sep 30, 2025 55.88 Mn
Jun 30, 2025 55.15 Mn
Mar 31, 2025 11.79 Mn
Dec 31, 2024 64.28 Mn
Sep 30, 2024 1.08 Mn
Jun 30, 2024 72.07 Mn
Mar 31, 2024 70.06 Mn
Dec 31, 2023 71.87 Mn
Sep 30, 2023 68.69 Mn
Jun 30, 2023 68.58 Mn
Mar 31, 2023 70.13 Mn
Dec 31, 2022 67.95 Mn
Sep 30, 2022 78.42 Mn
Sep 30, 2021 14,000.00
Jun 30, 2021 45,000.00
Mar 31, 2021 77,000.00
Dec 31, 2020 106,000.00
Sep 30, 2020 136,000.00